VERTEX PHARMACEUTICALS INC / MA (VRTX)

Import this data to Google Sheets with:

=jivedata("VRTX","financials")

Full statements spill as a table. For one cell: =jivedata("VRTX","Revenue") or =jivedata("VRTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

VERTEX PHARMACEUTICALS INC / MA

VRTX • CIK 0000875320

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$9,869,200	$11,020,100	$12,001,300	$12,587,200
Operating Income (Loss)	$3,832,000	$-232,900	$4,173,300	$4,777,100
Investment Income, Interest and Dividend	$614,700	$598,100	$490,900	$490,900
InterestExpenseNonoperating	—	$30,600	$13,300	$13,300
Other Nonoperating Income (Expense)	$-22,800	$-86,100	$-7,700	$21,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$4,379,800	$248,500	$4,643,200	$5,274,500
Income Tax Expense (Benefit)	$760,200	$784,100	$690,000	$869,300
Net Income (Loss) Attributable to Parent	$3,619,600	$-535,600	$3,953,200	$4,405,200
Cost of Goods and Services Sold	$1,262,200	$1,530,500	$1,651,300	$1,762,800
Research and Development Expense (Excluding Acquired in Process Cost)	$3,162,900	$3,630,300	$3,909,500	$3,906,800
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$527,100	$4,628,400	$133,000	$132,900
Selling, General and Administrative Expense	$1,136,600	$1,464,300	$1,753,100	$2,008,000
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	—	—	$379,000	$0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-51,600	$-500	$2,100	$-400
Costs and Expenses	$6,037,200	$11,253,000	$7,828,000	$7,810,100
Weighted Average Number of Shares Outstanding, Basic	257,700,000	257,900,000	255,700,000	252,800,000
Weighted Average Number of Shares Outstanding, Diluted	260,500,000	257,900,000	258,000,000	254,500,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$10,369,100	$4,569,600	$5,084,800	$6,143,500
Marketable Securities, Current	$849,200	$1,546,300	$1,523,300	$1,708,900
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$1,159,300	$1,227,800	$1,520,300	$1,665,000
Accounts Receivable, after Allowance for Credit Loss, Current	$1,563,400	$1,609,400	$2,052,800	$2,134,300
Goodwill	$1,088,000	$1,088,000	$1,088,000	$1,088,000
Inventory, Net	$738,800	$1,205,400	$1,686,800	$1,765,100
Intangible Assets, Net (Excluding Goodwill)	$839,900	$825,900	$424,200	$412,800
Prepaid Expense and Other Assets, Current	$623,700	$665,700	$853,300	$791,900
Deferred Income Tax Assets, Net	$1,812,100	$2,331,100	$2,897,900	$3,010,900
Assets, Current	$14,144,200	$9,596,400	$11,201,000	$12,543,700
Operating Lease, Right-of-Use Asset	$293,600	$1,356,800	$1,562,700	$1,662,900
Marketable Securities, Noncurrent	$2,497,800	$5,107,900	$5,712,300	$5,789,100
Other Assets, Noncurrent	$895,300	$999,300	$1,236,600	$1,250,900
Assets	$22,730,200	$22,533,200	$25,643,000	$27,423,300
Operating Lease, Liability, Noncurrent	$348,600	$1,544,400	$1,846,500	$1,977,600
Other Liabilities, Noncurrent	$877,700	$901,800	$1,269,500	$1,259,900
Liabilities	$5,149,800	$6,123,600	$6,977,200	$7,175,400
Accounts Payable, Current	$364,900	$413,000	$461,700	$429,500
Accrued Liabilities, Current	$2,655,300	$2,788,600	$2,971,200	$3,179,000
Other Liabilities, Current	$527,200	$363,000	$428,300	$329,400
Liabilities, Current	$3,547,400	$3,564,600	$3,861,200	$3,937,900
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2,600	$2,600	$2,500	$2,500
Additional Paid in Capital, Common Stock	$7,449,700	$6,672,400	$5,119,200	$4,505,700
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-14,300	$127,800	$-15,900	$48,500
Retained Earnings (Accumulated Deficit)	$10,142,400	$9,606,800	$13,560,000	$15,691,200
Stockholders' Equity Attributable to Parent	$17,580,400	$16,409,600	$18,665,800	$20,247,900
Preferred Stock, Shares Authorized	1,000,000	1,000,000	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	257,695,221	256,940,382	253,991,224	253,347,555
Restricted Cash and Cash Equivalents	$3,200	$2,600	$3,000	$10,600
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$10,372,300	$4,572,200	$5,087,800	$6,154,100
Prepaid Expense, Current	$108,600	$102,200	$101,700	$101,700
Cash Flow Hedge Derivative Instrument Assets at Fair Value	$1,800	$130,100	$6,200	$6,200
Other Assets, Current	$84,300	$76,400	$110,900	$110,900
Capitalized Computer Software, Gross	$58,900	$62,600	$66,600	$66,600
Capitalized Computer Software, Amortization	$11,800	$25,200	$31,200	$31,200
Employee-related Liabilities, Current	$295,000	$352,100	$397,700	$397,700
Accrued Royalties, Current	$237,600	$271,000	$276,700	$276,700
Taxes Payable, Current	$99,500	$161,100	$103,100	$103,100
Other Accrued Liabilities, Current	$41,600	$66,300	$46,700	$46,700
Operating Lease, Liability, Current	$33,100	$87,100	$77,300	$77,300
Derivative Liability, Current	—	—	$79,400	$79,400
Other Sundry Liabilities, Current	$73,200	$31,400	$48,300	$48,300
Finance Lease, Liability, Noncurrent	$376,100	$112,800	$106,700	$106,700
Business Combination, Contingent Consideration, Liability, Noncurrent	$77,400	$76,900	$79,000	$79,000
Other Sundry Liabilities, Noncurrent	$118,900	$126,300	$188,400	$188,400
Operating Lease, Liability	$381,700	$1,631,500	$1,923,800	$1,923,800
Finance Lease, Liability, Current	$50,600	$5,200	$5,500	$5,500
Finance Lease, Liability	$426,700	$118,000	$112,200	$112,200
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$272,800	$57,900	$81,500	$81,500

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$3,619,600	$-535,600	$3,953,200	$4,405,200
Net Cash Provided by (Used in) Operating Activities	$3,537,300	$-492,600	$3,631,400	$4,292,900
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$26,900	$-42,600	$90,900	$-40,800
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-139,700	$-5,800,100	$515,600	$1,172,100
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$10,372,300	$4,572,200	$5,087,800	$5,907,300
Share-based Payment Arrangement, Noncash Expense	$581,200	$698,500	$685,900	$689,100
Payments to Acquire Debt Securities, Available-for-sale	$3,786,500	$7,438,200	$6,396,500	$7,440,000
Depreciation, Depletion and Amortization	$181,300	$207,200	$209,800	$222,100
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$839,100	$4,465,600	$5,897,400	$6,979,300
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	—	—	$379,000	$0
Payments to Acquire Property, Plant, and Equipment	$200,400	$297,700	$437,600	$496,800
Increase (Decrease) in Other Deferred Liability	$-536,500	$-348,800	$-510,800	$-340,400
ProceedsFromSaleOfEquitySecuritiesFvNi	$95,100	$0	$16,000	$16,000
Other Noncash Income (Expense)	$-8,400	$56,300	$-113,400	$5,000
Payments for (Proceeds from) Other Investing Activities	—	$54,000	$24,700	$16,800
Net Cash Provided by (Used in) Investing Activities	$-3,141,700	$-3,770,000	$-945,400	$-882,800
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$134,600	$114,600	$127,700	$136,600
Payments for Repurchase of Common Stock	$427,600	$1,177,100	$2,017,400	$2,005,900
Payment, Tax Withholding, Share-based Payment Arrangement	$226,100	$405,000	$369,900	$326,300
Finance Lease, Principal Payments	$44,900	$33,600	$5,400	$5,400
Proceeds from (Payments for) Other Financing Activities	—	$6,200	$3,700	$1,200
Net Cash Provided by (Used in) Financing Activities	$-562,200	$-1,494,900	$-2,261,300	$-2,197,200
Income Taxes Paid, Net	$1,677,300	$1,082,100	$1,566,700	$1,370,500
Interest Paid, Excluding Capitalized Interest, Operating Activities	$43,100	$30,500	$12,400	$12,500
Increase (Decrease) in Accounts Receivable	$84,100	$99,300	$347,300	$259,700
Increase (Decrease) in Inventories	$322,900	$517,300	$524,200	$333,900
Increase (Decrease) in Prepaid Expense and Other Assets	$545,700	$200,300	$396,000	$169,500
Increase (Decrease) in Accounts Payable	$48,700	$49,500	$36,800	$-28,100
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$429,400	$212,900	$-116,900	$-38,600
Increase (Decrease) in Other Operating Liabilities	$208,900	$39,700	$148,500	$161,300

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VRTX","financials")

Full statements spill as a table. For one cell: =jivedata("VRTX","Revenue") or =jivedata("VRTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.